Thames Water rival bondholders face off in court hearing
Read more at Financial Times
-
Crunch week for UK's Thames Water as regulator rules, court process starts
Thames Water, the British utility that risks running out of cash, faces a crunch week, as the water regulator sets future prices, and a court process begins that should help it to secure a 3 ...Yahoo Sports - 2d -
Reform UK calls for Thames Water to be renationalised
Populist party’s deputy leader says heavily indebted utility should ‘be put out of its misery’Financial Times - 5d -
Idaho's strict abortion ban faces scrutiny in federal appeals court hearing
A federal appeals court is scrutinizing the impact of Idaho’s strict abortion ban on emergency medical careABC News - Dec. 10 -
Thames Water boss defends exec bonuses as sewage spills soar
The company saw a 40% increase in pollution incidents in the first half of the year as its debts continued to swell.BBC News - Dec. 10 -
Bidders line up for struggling Thames Water
The water firm has received multiple bids as it faces running out of money next year.BBC News - Dec. 6 -
Thames Water receives bid from Covalis and France’s Suez
UK investor is teaming up with French group as part of a bid for control of troubled utilityFinancial Times - Dec. 5 -
Canary Wharf bondholders sign off on £610mn refinancing
Docklands landlord faces higher debt costs and a challenging backdrop for office buildingsFinancial Times - Dec. 4 -
Thames Water creditors veto use of £3bn loan to pay fines
Troubled utility faces fines of £400mn by March 2027 as it tries to avoid renationalisationFinancial Times - Dec. 3 -
Who takes charge when Thames Water has no shareholders?
Not literally, but effectivelyFinancial Times - Nov. 26
More from Financial Times
-
UK inflation rises to 2.6% in November
Financial Times - 5h -
The vast spy agency behind Russian general’s death
Financial Times - 2h -
Economics can’t explain all the anger of voters
Financial Times - 2h -
China’s ‘magic weapon’ helping Beijing wield influence in the UK
Financial Times - 8h -
Merck strikes $2bn deal with Chinese biotech to develop oral weight-loss drug
Financial Times - 8h